MAGNEVIST Side Effects

7022574-7 | Emotional Distress, Erythema, Fibrosis, Joint Range Of Motion Decreased, Mobility Decreased, Musculoskeletal Stiffness, Nephrogenic Systemic Fibrosis, Oedema Peripheral
on Sep 20, 2010 Male patient from UNITED STATES , 67 years of age, weighting 154.3 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: emotional distress, erythema, fibrosis, joint range of motion decreased, mobility decreased, musculoskeletal stiffness, nephrogenic systemic fibrosis, oedema peripheral. Magnevist dosage: Magnevist Dose Illegible/60 Ml Visipaque. During the same period patient was treated with OPTIMARK (As Used: 20 Ml) (View Optimark Review and Optimark Label ), OMNISCAN (View Omniscan Review and Omniscan Label ), VISIPAQUE (Magnevist Dose Illegible/60 Ml Visipaque) (View Visipaque Review and Visipaque Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), METAPROLOL (View Metaprolol Review and Metaprolol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ).

7021195-X | Nausea
Patient was taking Magnevist (View Usage). Patient had the following side effects: nausea (What is nausea?) on Sep 16, 2010 from UNITED STATES Additional patient health information: Male patient , 46 years of age, weighting 324.1 lb, was diagnosed with nuclear magnetic resonance imaging brain and. Magnevist dosage: Total Daily Dose: 10 Ml Unit Dose: 100 Ml.

7021063-3 | Anhedonia, Anxiety, Balance Disorder, Dry Skin, Dysstasia, Gait Disturbance, Nephrogenic Systemic Fibrosis, Pain
Adverse event was reported on Sep 07, 2010 by a Male patient taking Magnevist (View Usage) (Dosage: ) was diagnosed with nuclear magnetic resonance imaging and. Location: UNITED STATES , 33 years of age, After Magnevist was administered, patient had the following side effects: anhedonia, anxiety (What is anxiety?), balance disorder, dry skin, dysstasia, gait disturbance, nephrogenic systemic fibrosis, pain (What is pain?). During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ).

7016282-6 | Cough, Nasal Congestion, Nasal Discomfort, Throat Irritation
on Aug 23, 2010 Female patient from UNITED STATES , 51 years of age, weighting 149.9 lb, was diagnosed with deafness and was treated with Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: cough, nasal congestion, nasal discomfort, throat irritation. Magnevist dosage: Total Daily Dose: 15 Ml Unit Dose: 15 Ml.


7016279-6 | Dysgeusia, Lacrimation Increased, Rhinorrhoea
on Aug 23, 2010 Male patient from UNITED STATES , 47 years of age, was diagnosed with brain neoplasm and was treated with Magnevist (View Usage). Patient had the following side effects: dysgeusia, lacrimation increased, rhinorrhoea. Magnevist dosage: As Used: 14 Ml Unit Dose: 20 Ml.

7013841-1 | Erythema, Pruritus, Urticaria
Patient was taking Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: erythema, pruritus, urticaria on Aug 25, 2010 from UNITED STATES Additional patient health information: Female patient , 56 years of age, weighting 156.5 lb, was diagnosed with nuclear magnetic resonance imaging brain and. Magnevist dosage: Total Daily Dose: 14 Ml Unit Dose: 15 Ml. During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ).

7013840-X | Vomiting
Adverse event was reported on Sep 09, 2010 by a Male patient taking Magnevist (View Usage) (Dosage: Total Daily Dose: 15 Ml) was diagnosed with nuclear magnetic resonance imaging brain and. Location: UNITED STATES , 53 years of age, Patient experienced the following unwanted or unexpected effects: vomiting.

7013839-3 | Pruritus
on Sep 09, 2010 Female patient from UNITED STATES , 39 years of age, was diagnosed with nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). Patient had the following side effects: pruritus. Magnevist dosage: .

7013832-0 | Erythema, Pruritus, Urticaria
on Sep 08, 2010 Female patient from UNITED STATES , 43 years of age, weighting 189.6 lb, was diagnosed with nuclear magnetic resonance imaging brain and was treated with Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: erythema, pruritus, urticaria. Magnevist dosage: Total Daily Dose: 18 Ml Unit Dose: 20 Ml.

7013829-0 | Dizziness, Nausea
Patient was taking Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), nausea (What is nausea?) on Aug 19, 2010 from UNITED STATES Additional patient health information: Female patient , 41 years of age, was diagnosed with nuclear magnetic resonance imaging brain and. Magnevist dosage: Total Daily Dose: 15 Ml Unit Dose: 20 Ml.

7013825-3 | Pruritus, Rash, Throat Irritation
Adverse event was reported on Sep 08, 2010 by a Male patient taking Magnevist (View Usage) (Dosage: As Used: 30 Ml) was diagnosed with nuclear magnetic resonance imaging and. Location: UNITED STATES , 44 years of age, weighting 330.7 lb, Patient had the following side effects: pruritus, rash (What is rash?), throat irritation.

7013817-4 | Pruritus, Urticaria
on Sep 02, 2010 Female patient from UNITED STATES , 74 years of age, was diagnosed with nuclear magnetic resonance imaging thoracic and was treated with Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: pruritus, urticaria. Magnevist dosage: As Used: 20 Ml.

7013502-9 | Blood Pressure Increased, Head Discomfort, Heart Rate Increased, Nausea
on Sep 14, 2010 Female patient from UNITED STATES , 48 years of age, was diagnosed with nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, head discomfort, heart rate increased, nausea (What is nausea?). Magnevist dosage: Total Daily Dose: 10 Ml Unit Dose: 10 Ml. During the same period patient was treated with VOLTAREN (View Voltaren Review and Voltaren Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ).

7012280-7 | Cardio-respiratory Arrest, Coma, Contrast Media Reaction
Patient was taking Magnevist (View Usage). Patient had the following side effects: cardio-respiratory arrest, coma, contrast media reaction on Sep 22, 2010 from UNITED STATES Additional patient health information: Female patient , 38 years of age, weighting 280.0 lb, was diagnosed with liver disorder and. Magnevist dosage: 20 Ml 1 Iv.

7009988-6 | Asthenia, Blood Pressure Decreased, Discomfort, Disturbance In Attention, Dysgeusia, Feeling Hot, Lethargy, Mental Status Changes, Neurological Examination Abnormal
Adverse event was reported on Sep 09, 2010 by a Male patient taking Magnevist (View Usage) (Dosage: Total Daily Dose: 19 Ml) was diagnosed with lower extremity mass and. Location: UNITED STATES , 55 years of age, After Magnevist was administered, patient had the following side effects: asthenia, blood pressure decreased, discomfort, disturbance in attention, dysgeusia, feeling hot, lethargy, mental status changes, neurological examination abnormal.

7007885-3 | Deformity, Hyperkeratosis, Joint Stiffness, Lichen Planus, Nephrogenic Systemic Fibrosis, Pain, Pruritus, Rash
on Sep 08, 2010 Female patient from UNITED STATES , 57 years of age, weighting 119.0 lb, was diagnosed with nuclear magnetic resonance imaging, nuclear magnetic resonance imaging brain and was treated with Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: deformity, hyperkeratosis, joint stiffness, lichen planus, nephrogenic systemic fibrosis, pain (What is pain?), pruritus, rash (What is rash?). Magnevist dosage: . During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ).

7007880-4 | Anaphylactic Reaction, Cough, Dyspnoea, Nasal Congestion, Pharyngeal Oedema, Swollen Tongue, Throat Tightness
on Sep 17, 2010 Female patient from UNITED STATES , 71 years of age, was diagnosed with angiogram and was treated with Magnevist (View Usage). Patient had the following side effects: anaphylactic reaction, cough, dyspnoea, nasal congestion, pharyngeal oedema, swollen tongue, throat tightness. Magnevist dosage: Total Daily Dose: 20 Ml Unit Dose: 20 Ml. Patient was hospitalized.

7006540-3 | Contrast Media Reaction, Swelling
Patient was taking Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: contrast media reaction, swelling on Sep 21, 2010 from UNITED STATES Additional patient health information: Female patient , 60 years of age, was diagnosed with surgery (What is surgery?) and. Magnevist dosage: 12 Ml Iv Bolus.

7005199-9 | Urticaria
Adverse event was reported on Sep 09, 2010 by a Female patient taking Magnevist (View Usage) (Dosage: As Used: 20 Ml Unit Dose: 20 Ml) was diagnosed with nuclear magnetic resonance imaging brain and. Location: UNITED STATES , 26 years of age, Patient experienced the following unwanted or unexpected effects: urticaria.

7005190-2 | Asthenia, Discomfort, Disturbance In Attention, Dysgeusia, Feeling Abnormal, Feeling Hot, Hypotension, Lethargy, Mental Status Changes
on Sep 09, 2010 Female patient from UNITED STATES , 38 years of age, weighting 158.7 lb, was diagnosed with musculoskeletal pain and was treated with Magnevist (View Usage). Patient had the following side effects: asthenia, discomfort, disturbance in attention, dysgeusia, feeling abnormal, feeling hot, hypotension, lethargy, mental status changes. Magnevist dosage: Total Daily Dose: 4 Ml. During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ).

7005188-4 | Asthenia, Blood Pressure Decreased, Discomfort, Disturbance In Attention, Dysgeusia, Feeling Hot, Lethargy, Mental Status Changes, Neurological Examination Abnormal
on Sep 09, 2010 Male patient from UNITED STATES , 55 years of age, was diagnosed with lower extremity mass and was treated with Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: asthenia, blood pressure decreased, discomfort, disturbance in attention, dysgeusia, feeling hot, lethargy, mental status changes, neurological examination abnormal. Magnevist dosage: Total Daily Dose: 19 Ml.

7005187-2 | Cough, Dyspnoea, Flushing, Hypersensitivity, Sneezing
Patient was taking Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: cough, dyspnoea, flushing, hypersensitivity, sneezing on Sep 14, 2010 from UNITED STATES Additional patient health information: Female patient , 28 years of age, weighting 134.5 lb, was diagnosed with nuclear magnetic resonance imaging brain and. Magnevist dosage: Total Daily Dose: 10 Ml Unit Dose: 10 Ml.

7005183-5 | Arthralgia, Deformity, Erythema, Fibrosis, Joint Range Of Motion Decreased, Mobility Decreased, Musculoskeletal Stiffness, Nephrogenic Systemic Fibrosis
Adverse event was reported on Sep 07, 2010 by a Male patient taking Magnevist (View Usage) (Dosage: Total Daily Dose: 20 Ml) was diagnosed with nuclear magnetic resonance imaging brain and. Location: UNITED STATES , 53 years of age, weighting 209.4 lb, Patient had the following side effects: arthralgia, deformity, erythema, fibrosis, joint range of motion decreased, mobility decreased, musculoskeletal stiffness, nephrogenic systemic fibrosis. During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), MULTIHANCE (View Multihance Review and Multihance Label ).

7005181-1 | Deformity, Hyperkeratosis, Joint Stiffness, Lichen Planus, Nephrogenic Systemic Fibrosis, Pain, Pruritus, Rash
on Sep 08, 2010 Female patient from UNITED STATES , 57 years of age, weighting 119.0 lb, was diagnosed with nuclear magnetic resonance imaging, nuclear magnetic resonance imaging brain and was treated with Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: deformity, hyperkeratosis, joint stiffness, lichen planus, nephrogenic systemic fibrosis, pain (What is pain?), pruritus, rash (What is rash?). Magnevist dosage: . During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ).

7005177-X | Anhedonia, Anxiety, Balance Disorder, Dry Skin, Dysstasia, Gait Disturbance, Nephrogenic Systemic Fibrosis, Pain
on Sep 07, 2010 Male patient from UNITED STATES , 33 years of age, was diagnosed with nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: anhedonia, anxiety (What is anxiety?), balance disorder, dry skin, dysstasia, gait disturbance, nephrogenic systemic fibrosis, pain (What is pain?). Magnevist dosage: . During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ).

7000464-3 | Lip Swelling, Sneezing
Patient was taking Magnevist (View Usage). Patient had the following side effects: lip swelling, sneezing on Aug 27, 2010 from UNITED STATES Additional patient health information: Female patient , 56 years of age, was diagnosed with scan and. Magnevist dosage: .

7000354-6 | Pruritus, Urticaria
Adverse event was reported on Sep 09, 2010 by a Female patient taking Magnevist (View Usage) (Dosage: ) was diagnosed with nuclear magnetic resonance imaging brain and. Location: UNITED STATES , 36 years of age, After Magnevist was administered, patient had the following side effects: pruritus, urticaria.

7000347-9 | Injection Site Mass, Injection Site Pain, Soft Tissue Injury
on Sep 01, 2010 Female patient from UNITED STATES , 44 years of age, was diagnosed with nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: injection site mass, injection site pain, soft tissue injury. Magnevist dosage: .

7000345-5 | Urticaria
on Aug 16, 2010 Female patient from UNITED STATES , 77 years of age, was diagnosed with nuclear magnetic resonance imaging abdominal and was treated with Magnevist (View Usage). Patient had the following side effects: urticaria. Magnevist dosage: Total Daily Dose: 30 Ml.

6992356-0 | Arthralgia, Deformity, Erythema, Fibrosis, Joint Range Of Motion Decreased, Mobility Decreased, Musculoskeletal Stiffness, Nephrogenic Systemic Fibrosis
Patient was taking Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: arthralgia, deformity, erythema, fibrosis, joint range of motion decreased, mobility decreased, musculoskeletal stiffness, nephrogenic systemic fibrosis on Sep 07, 2010 from UNITED STATES Additional patient health information: Male patient , 53 years of age, weighting 209.4 lb, was diagnosed with nuclear magnetic resonance imaging brain and. Magnevist dosage: Total Daily Dose: 20 Ml. During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), MULTIHANCE (View Multihance Review and Multihance Label ).

6985702-5 | Dyspnoea, Pruritus, Urticaria
Adverse event was reported on Sep 08, 2010 by a Female patient taking Magnevist (View Usage) (Dosage: Total Daily Dose: 15 Ml) was diagnosed with nuclear magnetic resonance imaging and. Location: UNITED STATES , 72 years of age, Patient experienced the following unwanted or unexpected effects: dyspnoea, pruritus, urticaria.

6984964-8 | Cough, Dyspnoea, Flushing, Sneezing
on Sep 10, 2010 Female patient from UNITED STATES , 28 years of age, was diagnosed with nuclear magnetic resonance imaging brain and was treated with Magnevist (View Usage). Patient had the following side effects: cough, dyspnoea, flushing, sneezing. Magnevist dosage: Total Daily Dose: 10 Ml.

6980453-5 | Cough, Dyspnoea, Flushing, Sneezing
on Sep 10, 2010 Female patient from UNITED STATES , 28 years of age, was diagnosed with nuclear magnetic resonance imaging brain and was treated with Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: cough, dyspnoea, flushing, sneezing. Magnevist dosage: Total Daily Dose: 10 Ml.

6980451-1 | Burning Sensation, Erythema, Extremity Contracture, Fibrosis, Joint Contracture, Joint Lock, Joint Range Of Motion Decreased, Joint Stiffness
Patient was taking Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: burning sensation, erythema, extremity contracture, fibrosis, joint contracture, joint lock, joint range of motion decreased, joint stiffness on Sep 02, 2010 from UNITED STATES Additional patient health information: Female patient , 33 years of age, weighting 191.8 lb, was diagnosed with angiogram, nuclear magnetic resonance imaging and. Magnevist dosage: . During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), PROHANCE (Total Daily Dose: 20 Ml) (View Prohance Review and Prohance Label ), MULTIHANCE (View Multihance Review and Multihance Label ), GABITRIL (View Gabitril Review and Gabitril Label ), RENAGEL (As Used: 800 Mg Unit Dose: 800 Mg) (View Renagel Review and Renagel Label ).

6980449-3 | Dyspnoea
Adverse event was reported on Sep 08, 2010 by a Female patient taking Magnevist (View Usage) (Dosage: Total Daily Dose: 20 Ml) was diagnosed with nuclear magnetic resonance imaging brain, migraine (What is migraine?) and. Location: UNITED STATES , 32 years of age, weighting 246.9 lb, Patient had the following side effects: dyspnoea. During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), EXCEDRIN (MIGRAINE) (View Excedrin (migraine) Review and Excedrin (migraine) Label ).

6973390-3 | Anhedonia, Anxiety, Arthralgia, Azotaemia, Back Pain, Balance Disorder, Coordination Abnormal, Emotional Distress, Fatigue
on Aug 31, 2010 Male patient from UNITED STATES , 54 years of age, weighting 335.1 lb, was diagnosed with nuclear magnetic resonance imaging abdominal and was treated with Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: anhedonia, anxiety (What is anxiety?), arthralgia, azotaemia, back pain (What is back pain?), balance disorder, coordination abnormal, emotional distress, fatigue. Magnevist dosage: Total Daily Dose: 40 Ml. During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), MULTIHANCE (View Multihance Review and Multihance Label ).

6973389-7 | Burning Sensation, Erythema, Extremity Contracture, Fibrosis, Joint Contracture, Joint Lock, Joint Range Of Motion Decreased, Joint Stiffness
on Sep 02, 2010 Female patient from UNITED STATES , 33 years of age, weighting 191.8 lb, was diagnosed with angiogram, nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: burning sensation, erythema, extremity contracture, fibrosis, joint contracture, joint lock, joint range of motion decreased, joint stiffness. Magnevist dosage: . During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), PROHANCE (Total Daily Dose: 20 Ml) (View Prohance Review and Prohance Label ), MULTIHANCE (View Multihance Review and Multihance Label ), GABITRIL (View Gabitril Review and Gabitril Label ), RENAGEL (As Used: 800 Mg Unit Dose: 800 Mg) (View Renagel Review and Renagel Label ).

6973388-5 | Anxiety, Emotional Distress, Fibrosis, Injury, Mobility Decreased, Nephrogenic Systemic Fibrosis, Pain, Skin Oedema
Patient was taking Magnevist (View Usage). Patient had the following side effects: anxiety (What is anxiety?), emotional distress, fibrosis, injury, mobility decreased, nephrogenic systemic fibrosis, pain (What is pain?), skin oedema on Aug 31, 2010 from UNITED STATES Additional patient health information: Female patient , 39 years of age, was diagnosed with nuclear magnetic resonance imaging, pain (What is pain?), iron deficiency, prophylaxis against transplant rejection, hypertension, medical diet and. Magnevist dosage: . During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), VICODIN (View Vicodin Review and Vicodin Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), PROGRAF (View Prograf Review and Prograf Label ), LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), RENA VITE (View Rena-vite Review and Rena-vite Label ).

6970310-2 | Heart Rate Decreased, Nausea, Respiratory Rate Decreased, Urticaria
Adverse event was reported on Aug 25, 2010 by a Male patient taking Magnevist (View Usage) (Dosage: ) . Location: UNITED STATES , 75 years of age, After Magnevist was administered, patient had the following side effects: heart rate decreased, nausea (What is nausea?), respiratory rate decreased, urticaria. During the same period patient was treated with STEROIDS (Being Weaned Off) (View Steroids Review and Steroids Label ).

6970309-6 | Eye Pruritus, Eye Swelling, Swelling Face
on Aug 27, 2010 Male patient from UNITED STATES , 17 years of age, was treated with Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: eye pruritus, eye swelling, swelling face. Magnevist dosage: .

6970301-1 | Anhedonia, Anxiety, Emotional Distress, Exfoliative Rash, Joint Stiffness, Mobility Decreased, Nephrogenic Systemic Fibrosis, Oedema Peripheral, Pain
on Aug 31, 2010 Female patient from UNITED STATES , 70 years of age, was diagnosed with nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). Patient had the following side effects: anhedonia, anxiety (What is anxiety?), emotional distress, exfoliative rash, joint stiffness, mobility decreased, nephrogenic systemic fibrosis, oedema peripheral, pain (What is pain?). Magnevist dosage: .

6970300-X | Anxiety, Emotional Distress, Fibrosis, Injury, Nephrogenic Systemic Fibrosis, Pain, Scar, Skin Fibrosis
Patient was taking Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: anxiety (What is anxiety?), emotional distress, fibrosis, injury, nephrogenic systemic fibrosis, pain (What is pain?), scar (What is scar?), skin fibrosis on Aug 31, 2010 from UNITED STATES Additional patient health information: Male patient , 61 years of age, was diagnosed with nuclear magnetic resonance imaging and. Magnevist dosage: .

6970299-6 | Abasia, Arthralgia, Joint Swelling, Nephrogenic Systemic Fibrosis, Pain In Extremity
Adverse event was reported on Aug 31, 2010 by a Male patient taking Magnevist (View Usage) (Dosage: ) was diagnosed with nuclear magnetic resonance imaging and. Location: UNITED STATES , 54 years of age, weighting 134.5 lb, Patient experienced the following unwanted or unexpected effects: abasia, arthralgia, joint swelling, nephrogenic systemic fibrosis, pain in extremity. During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), PROCARDIA XL (90 Bid) (View Procardia Xl Review and Procardia Xl Label ), EPO (Per Protocol) (View Epo Review and Epo Label ), HOLDIRON (Per Protocol) (View Holdiron Review and Holdiron Label ), HEPARIN (1000/500) (View Heparin Review and Heparin Label ), ASPIRIN (Total Daily Dose: 81 Mg) (View Aspirin Review and Aspirin Label ), KALETRA (2 Tablets Every 12 Hours) (View Kaletra Review and Kaletra Label ).

6970298-4 | Anxiety, Emotional Distress, Fibrosis, Injury, Nephrogenic Systemic Fibrosis, Pain, Scar
on Aug 31, 2010 Male patient from UNITED STATES , 56 years of age, was diagnosed with nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). Patient had the following side effects: anxiety (What is anxiety?), emotional distress, fibrosis, injury, nephrogenic systemic fibrosis, pain (What is pain?), scar (What is scar?). Magnevist dosage: . During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ).

6967793-0 | Heart Rate Decreased, Nausea, Respiratory Rate Decreased, Urticaria
on Aug 25, 2010 Male patient from UNITED STATES , 75 years of age, was treated with Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: heart rate decreased, nausea (What is nausea?), respiratory rate decreased, urticaria. Magnevist dosage: . During the same period patient was treated with STEROIDS (Being Weaned Off) (View Steroids Review and Steroids Label ).

6967788-7 | Bradycardia, Dysarthria, Hyperhidrosis, Vomiting
Patient was taking Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, dysarthria, hyperhidrosis, vomiting on Aug 31, 2010 from AUSTRALIA Additional patient health information: Male patient , 36 years of age, was diagnosed with nuclear magnetic resonance imaging and. Magnevist dosage: .

6966217-7 | Anhedonia, Anxiety, Back Pain, Emotional Distress, Exfoliative Rash, Gait Disturbance, Hyperkeratosis, Joint Range Of Motion Decreased, Muscle Fatigue
Adverse event was reported on Aug 24, 2010 by a Female patient taking Magnevist (View Usage) (Dosage: ) was diagnosed with nuclear magnetic resonance imaging brain, nuclear magnetic resonance imaging abdominal, gastrooesophageal reflux disease, wheezing and. Location: UNITED STATES , 33 years of age, weighting 194.0 lb, Patient had the following side effects: anhedonia, anxiety (What is anxiety?), back pain (What is back pain?), emotional distress, exfoliative rash, gait disturbance, hyperkeratosis, joint range of motion decreased, muscle fatigue. During the same period patient was treated with OMNISCAN (Total Daily Dose: 40 Ml) (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), MULTIHANCE (View Multihance Review and Multihance Label ), PROHANCE (View Prohance Review and Prohance Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), ALBUTEROL SULATE (View Albuterol Sulate Review and Albuterol Sulate Label ).

6965097-3 | Urticaria
on Aug 13, 2010 Male patient from UNITED STATES , 78 years of age, was diagnosed with nuclear magnetic resonance imaging brain and was treated with Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: urticaria. Magnevist dosage: .

6965095-X | Pruritus, Urticaria
on Aug 23, 2010 Female patient from UNITED STATES , 70 years of age, weighting 172.0 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: pruritus, urticaria. Magnevist dosage: Total Daily Dose: 16 Ml Unit Dose: 100 Ml. During the same period patient was treated with VALIUM (Total Daily Dose: 10 Mg) (View Valium Review and Valium Label ), METFORMIN (View Metformin Review and Metformin Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ).

6963584-5 | Deformity, Erythema, Fibrosis, Joint Stiffness, Nephrogenic Systemic Fibrosis, Oedema, Oedema Peripheral, Pain
Patient was taking Magnevist (View Usage). Patient had the following side effects: deformity, erythema, fibrosis, joint stiffness, nephrogenic systemic fibrosis, oedema, oedema peripheral, pain (What is pain?) on Aug 24, 2010 from UNITED STATES Additional patient health information: Female patient , 50 years of age, weighting 187.4 lb, was diagnosed with nuclear magnetic resonance imaging and. Magnevist dosage: . During the same period patient was treated with OMNISCAN (Total Daily Dose: 20 Ml) (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), MULTIHANCE (View Multihance Review and Multihance Label ), IRON (View Iron Review and Iron Label ), EPOGEN (View Epogen Review and Epogen Label ), OXOLAREN ULTRA (View Oxolaren-ultra Review and Oxolaren-ultra Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PROCRIT (View Procrit Review and Procrit Label ).